Cytiva released the Pegasus™ SV4 virus removal filter designed specifically for plasma processing with a defined design space to support robust filtration performance.
Public source
Publisher name
Public post
What makes virus filtration challenging in plasma fractionation? Unlike highly purified mAb processes, complex plasma feeds can significantly impact virus filter perform…
Company
Cytiva
We envision a world in which access to life-changing therapies transforms human health.
- Industry
- Biotechnology Research
- Location
- Global, OO
- Company size
- 5,001–10,000 employees
About Cytiva
Cytiva, now with the life sciences business from Pall Corporation, is a global biotechnology leader dedicated to helping customers discover and commercialize the next generation of therapeutics. We bring dedicated technical expertise and a broad portfolio of tools, technologies, and services that enable the development, manufacture, and delivery of transformative medicines to patients. We're the provider of leading life science brands such as ÄKTA, Amersham, HyClone, MabSelect and Whatman. We are part of Danaher, a global science and technology leader. Along with other Danaher businesses, we accelerate the impact of tomorrow’s science and technology innovation to improve human health. Visit https://www.cytiva.com/privacy to review our privacy policy.
See moreLatest activity
Latest activity from Cytiva
51 signals
Products & Services
Cytiva introduced process-specific filter validation services designed to support low and ultra-low product volumes.
Presence & Recognition
Cytiva completed Day 3 of the Exmouth to Newquay challenge, covering 156.7 km and 2,350 m of climbing.
Products & Services
Cytiva introduced HyClone boost expression supplements designed to support transient transfection workflows and increase recombinant protein and rAAV production.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
Thermo Fisher Scientific
Thermo Fisher Scientific released Part 5 of the DynaDrive bioreactor video series titled Aegis Advantage, featuring Aegis 5–14 film for media preparation through production.
Products & Services
Waters Corporation
Waters Corporation launched the Aura GT, a particle characterization device designed specifically for gene therapy development using sample volumes as low as 5 µL.
Products & Services
i3 Membrane
i3 Membrane launched the i3 DMC PrA 1.0 mL, which provides larger quantities of purified antibody material within the established DMC workflow through electrically driven elution instead of conventional low-pH elution buffers.
Products & Services
Merck Life Science
Merck Life Science released EMSURE® solvents specified beyond ACS grade to deliver broader regulatory coverage, higher purity, and more detailed documentation.
Products & Services
Eppendorf